The Orthopaedic Surgery Center Selects HSTpathways to Position for Future, Expansion & Enterprise-Wide Data Sharing

Orthopaedic Innovator in the ASC Industry Looks to High Performance
Management Solution to Improve Operational Efficiency

SAN FRANCISCO–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/ASC?src=hash” target=”_blank”gt;#ASClt;/agt;–HSTpathways,
the leading provider of cloud-based, ambulatory surgery center (ASC)
management software, today announced that The
Orthopaedic Surgery Center
will be deploying HSTpathways’ practice
management solution and eChart for new capabilities that include
streamlined operations, improved workflow, and facilitated reporting and
decision-making across the enterprise. Launched as the area’s first
outpatient joint replacement program in January 2015, The Orthopaedic
Surgery Center located in Boardman, Ohio, is an independent physician
owned, multi-specialty facility with physicians specializing in hand,
foot and ankle surgeries, sports medicine, shoulder and knee
replacements, and pain management. As demand for outpatient procedures
grows, the Center is building a new 13,000 square-feet ASC facility
expected to open November 2019. The Center is focused on delivering
efficient, low cost, high quality outpatient surgical care.


“HST provides a clear vision into the future of the ASC industry and a
consistent foundation for innovation,” said Taylor Cera, administrator
of The Orthopaedic Surgery Center. “HSTpathways has a great platform for
us, as it was built specifically for ASC organizations and workflows.
Designed to support enterprise level management, HST will help us to
make better decisions around standardizing supply lists across our
facilities, with physician preference cards, with payer contracts and
fee schedule updates. Other key benefits are that it’s easy to use,
supports data integration and is known for outstanding customer service.”

“HSTpathways is proud to collaborate with The Orthopaedic Surgery
Center, an ASC industry leader recognized for its innovative
technologies to enhance patient care,” said Tara
Vail
, COO of HSTpathways. “Our partnership represents an exciting
opportunity for the Center to better serve its patients through an
improved overall healthcare experience.”

HST works with ASCs of all sizes, with more than 750 clients, including
50 multi-facility corporate enterprises, ASC management companies, and
hundreds of free-standing ambulatory surgery centers and ASC-hospital
joint ventures.

About HSTpathways

HSTpathways
is a top-ranked, cloud-based Ambulatory Surgery Center software company
dedicated to serving the ASC industry. HST was named KLAS Category
Leader for Ambulatory Surgical Center Solutions in the “2018
Best in KLAS: Software & Services ”
 report. Clients include more
than 750 organizations such as freestanding ambulatory surgery centers
and ASC-hospital joint ventures, as well as 50 multi-facility corporate
enterprises. HSTpathways provides the most trusted enterprise software
management solution available to the ASC industry. HST offers
specialized software solutions to help ASC organizations achieve
efficiencies with surgical scheduling, supply chain management, EHR
clinical workflows, medical coding, insurance and patient billing, and
accounts receivable collections. For more information, visit www.HSTpathways.com.

Contacts

Kelly Motley
615.483.0365
Kelly.Motley@HSTpathways.com

Staff

Recent Posts

Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide

Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…

34 minutes ago

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…

34 minutes ago

Optinose Announces 1-for-15 Reverse Stock Split

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…

34 minutes ago

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…

34 minutes ago

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development…

34 minutes ago

SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation

TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or…

34 minutes ago